Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tzong Shin Tzai

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Urologic Oncology|April 15, 2004
The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancerTzong-Shin Tzai, Yuh-Shyan Tsai, Nan-Haw Chow
Urology|July 22, 2008
En bloc stapling of renal hilum during hand-assisted retroperitoneoscopic nephroureterectomy in dialysis patientsChien-Hui Ou, Wen-Horng Yang, Tzong-Shin Tzai
Urologia Internationalis|October 18, 2007
Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?Yuh-Shyan Tsai, Tzong-Shin Tzai, Nan-Hua Chow
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 22, 2006
Diagnostic performance of a random versus lesion-directed biopsy of the prostate from transrectal ultrasound: results of a 5-year consecutive clinical study in 1 institution in South TaiwanShih-Kai Lan, Yuh-Shyan Tsai, Yi-Hsiang Lin, et al.
Urology|December 20, 2005
Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tractYuh-Shyan Tsai, Tzong-Shin Tzai, Nan-Haw Chow, et al.
Advances in Urology|September 20, 2012
Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-AnalysisYuh-Shyan Tsai, Hong-Lin Cheng, Tzong-Shin Tzai, et al.
Clinical Therapeutics|July 10, 2007
Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in TaiwanYuh-Shyan Tsai, Shih-Kai Lan, Jiann-Hui Ou, et al.
Urology|January 18, 2002
Scrotal calcinosis presenting with prostatitis-like symptomsYuh Shyan Tsai, Tzong Shin Tzai, Johnny Shinn-Nan Lin, et al.
Journal of Clinical Medicine|March 10, 2022
Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting AnalysisChih-Yu Shen, Yeong-Chin Jou, Wei-Chih Kan, et al.
Urologic Oncology|June 30, 2019
Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancerYuh-Shyan Tsai, Yeong-Chin Jou, Hsin-Tzu Tsai, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Urologic Oncology|April 15, 2004
The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancerTzong-Shin Tzai, Yuh-Shyan Tsai, Nan-Haw Chow
Urology|July 22, 2008
En bloc stapling of renal hilum during hand-assisted retroperitoneoscopic nephroureterectomy in dialysis patientsChien-Hui Ou, Wen-Horng Yang, Tzong-Shin Tzai
Urologia Internationalis|October 18, 2007
Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?Yuh-Shyan Tsai, Tzong-Shin Tzai, Nan-Hua Chow
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 22, 2006
Diagnostic performance of a random versus lesion-directed biopsy of the prostate from transrectal ultrasound: results of a 5-year consecutive clinical study in 1 institution in South TaiwanShih-Kai Lan, Yuh-Shyan Tsai, Yi-Hsiang Lin, et al.
Urology|December 20, 2005
Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tractYuh-Shyan Tsai, Tzong-Shin Tzai, Nan-Haw Chow, et al.
Advances in Urology|September 20, 2012
Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-AnalysisYuh-Shyan Tsai, Hong-Lin Cheng, Tzong-Shin Tzai, et al.
Clinical Therapeutics|July 10, 2007
Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in TaiwanYuh-Shyan Tsai, Shih-Kai Lan, Jiann-Hui Ou, et al.
Urology|January 18, 2002
Scrotal calcinosis presenting with prostatitis-like symptomsYuh Shyan Tsai, Tzong Shin Tzai, Johnny Shinn-Nan Lin, et al.
Journal of Clinical Medicine|March 10, 2022
Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting AnalysisChih-Yu Shen, Yeong-Chin Jou, Wei-Chih Kan, et al.
Urologic Oncology|June 30, 2019
Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancerYuh-Shyan Tsai, Yeong-Chin Jou, Hsin-Tzu Tsai, et al.
Pageof 6